A. Jones - Concepedia

Author

A. Jones

Royal Marsden Hospital

Also Known As

A Jones, A L JONES, A L Jones, A. Jones, A. L. JONES, A. L. Jones, A.L. Jones, AL Jones, AdrianC Jones, Alison Jones

Publications

519

Citations

H-Index

Concepts

All Affiliations

Royal Marsden Hospital Royal Marsden NHS Foundation Trust University College London The Royal Free Hospital

About

A. Jones is an author at Royal Marsden Hospital specializing in breast cancer, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	295
2	Pharmacology	2	2	101
3	Engineering	1	1	26
4	Health Sciences	1	1	26
5	Nephrology	1	1	40

A. Jones

Publications

402

Citations

H-Index

Page 1

	Year	Citations
The Royal Marsden Hospital pilot tamoxifen chemoprevention trial T.J. Powles, A. Jones, S. Ashley, Breast Cancer Research and Treatment MedicineCancer ManagementClinical TrialsBreast CancerPharmacotherapy	1994	154
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients A. Jones, FA MacNeill, S. Jacobs, European Journal of Cancer Breast OncologyBreast Cancer PatientsMedicinePeripheral AromatisationIntramuscular 4-Hydroxyandrostenedione	1992	88
Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours Martyn Caplin, Waldemar A. Mielcarek, John Buscombe, Nuclear Medicine Communications	2000	48
The role of percutaneous nephrostomy in malignant urinary tract obstruction A.F. Watkinson, Roger A’Hern, A. Jones, Clinical Radiology Percutaneous NephrostomyUrological ResearchUrologySurgical OncologyGenitourinary Cancer	1993	40
Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer A. Jones, T.J. Powles, J. Oliff, British Journal of Cancer Bone ImagingEngineeringOncologic ImagingMedical ImagingBiomedical Imaging	1990	26
Fine Needle Aspiration Cytodiagnosis As A Pre‐Requisite For Primary Medical Treatment of Breast Cancer TJ Powles, P. A. Trott, G.R. Cherryman, Cytopathology	1991	19
The National Home and Hospice Care Survey: 1996 summary. Haupt Bj, A. Jones PubMed	1999	14
Abstract OT1-03-12: MANTA: A randomized phase II study of fulvestrant in combination with the dual mTOR inhibitor AZD2014 or everolimus or fulvestrant alone in estrogen receptor-positive advanced or metastatic breast cancer P. Schmid, Maria do Céu Ferreira, Suparna Dubey, Cancer Research Breast OncologyProfound Mtorc1 InhibitionFulvestrant AlonePharmacotherapyTumor Biology	2016	13

Page 1